Next Article in Journal
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
Next Article in Special Issue
Spatial Patterns of COVID-19 Vaccination Coverage by Social Vulnerability Index and Designated COVID-19 Vaccine Sites in Texas
Previous Article in Journal
The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines
Previous Article in Special Issue
A Multilingual App for Providing Information to SARS-CoV-2 Vaccination Candidates with Limited Language Proficiency: Development and Pilot
 
 
Article

Article Versions Notes

Vaccines 2022, 10(4), 507; https://doi.org/10.3390/vaccines10040507
Action Date Notes Link
article xml file uploaded 25 March 2022 02:11 CET Original file -
article xml uploaded. 25 March 2022 02:11 CET Update https://www.mdpi.com/2076-393X/10/4/507/xml
article pdf uploaded. 25 March 2022 02:11 CET Version of Record https://www.mdpi.com/2076-393X/10/4/507/pdf
article html file updated 25 March 2022 02:13 CET Original file -
article html file updated 1 August 2022 07:29 CEST Update https://www.mdpi.com/2076-393X/10/4/507/html
Back to TopTop